Hyun Park MD, PhD

Education

PhD - University of Texas M. D. Anderson Cancer Center
MD - Texas Tech University Health Science Center - El Paso
BSI - Baylor University

Representative Bibliography

- H.J. Park, K.C. Alcover, Q. Wang, S.M. Gada. SARS-CoV-2 Antibody Longitudinal Profile of Immune Globulin Preparations. Military Medicine, June 29, 2022. PMID: 35769049

- H.J. Park, N.L. Watson, R.H. Wauters, E.M. Lomasney, C.P. Punch, V.A. Dewyea, M.O. Evans, C.S. Chavarria, S.C. Wong, C.J. Calais, M.R. Kaplan, T.A. Banks, D.E. Beakes, D.J. Schwartz. Multisite evaluation of fire ant venom immunotherapy safety and efficacy. The Journal of Allergy and Clinical Immunology: Global, April 15, 2022. PMID: 37781270

- A.M. Waters, H.J. Park, A.L. Weskamp, A. Mateja, M.E. Kachur, J.J. Lyons, B.J. Rosen, N.A. Boggs. Elevated basal serum tryptase: disease distribution and variability in a regional health system. The Journal of Allergy and Clinical Immunology: In Practice, January 12, 2022. PMID: 35032694

- H.J. Park, D.I. Brooks, C.S. Chavarria, R.L. Wu, C.P. Mikita, D.E. Beakes. Combining Discordant Serum IgE and Skin Testing Improves Diagnostic and Therapeutic Accuracy for Hymenoptera Venom Hypersensitivity Immunotherapy. The Journal of Allergy and Clinical Immunology: In Practice, September 14, 2021. PMID:34534718

- H.J. Park, J.R. Montgomery, N.A. Boggs. Anaphylaxis After the Covid-19 Vaccine in a Patient with Cholinergic Urticaria. Military Medicine, April 14, 2021. PMID:33851711

- S. Rawal, F. Chu, M. Zhang, H.J. Park, D. Nattamai, S. Kannan, R. Sharma, D. Delgado, T. Chou, H.Y. Lin, V. Baladandayuthapani, A. Luong, F. Vega, N. Fowler, C. Dong, R.E. Davis, S.S. Neelapu. Cross Talk between Follicular Th Cells and Tumor Cells in Human Follicular Lymphoma Promotes Immune Evasion in the Tumor Microenvironment. Journal of Immunology, May 17, 2013. PMID:23686488

- J. Weng, S. Rawal, F. Chu, H.J. Park, R. Sharma, D.A. Delgado, L. Fayad, M. Fanale, J. Romaguera, A. Luong, L.W. Kwak, S.S. Neelapu. TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas. Blood, May 29, 2012. PMID:22645177

- H.J. Park, H. Qin, S.C. Cha, R. Sharma, Y. Chung, K.S. Schluns, S.S. Neelapu, W.W. Overwijk, P. Hwu, L.W. Kwak. Induction of TLR4-dependent CD8+ T cell immunity by murine beta-defensin2 fusion protein vaccines. Vaccine, 29:3476-3482, April 18, 2011. PMID:21382485

- H.J. Park, S.S. Neelapu. Developing idiotype vaccines for lymphoma: From preclinical studies to Phase III clinical trials. British Journal of Haematology, 142:179-191, June, 2008. PMID:18422783